The Last Chance Of Freedom

It's becoming increasingly difficult to discern fact from fiction, and unfortunately the media has a strong bias. They spin stories to make conservatives look bad and will go to great lengths to avoid reporting on the good that comes from conservative policies. There are a few shining lights in the media landscape-brave conservative outlets that report the truth and offer a different perspective. We must support conservative outlets like this one and ensure that our voices are heard.

Wednesday, February 1, 2023

Ivermectin: Could Population-Wide Distribution Have Prevented China’s Recent Mass COVID Outbreak?

The efficacy of ivermectin in treating early and mild COVID-19 infections was confirmed in large states such as Uttar Pradesh

using it in Uttar Pradesh dramatically reduced both the infection rate and the death toll.
When the Delta variant broke out in 2021 across India, many states offered the prophylactic population-wide
even among frontline health care workers it proved effective.

Ivermectin-The Wonder Drug

First used in Japan in the 70s as an anti-parasitic drug, it has made major inroads against two devastating tropical diseases, onchocerciasis and lymphatic filariasis.
In addition, it is effective against a host of viruses, including HIV-1, yellow fever, malaria, West Nile virus, Zika, dengue fever, etc.

Potential Mechanisms Against COVID

SARS-CoV-2 is a virus that takes over host cells to multiply in the body.
If the virus slips past the cell membrane, its top priority is to infiltrate the brain of the cell-the DNA-containing nucleus-to start mass-producing itself.
Ivermectin prevents the bonding process by interfering with the virus's spike proteins.

Ivermectin Could Reduce Severe Lung Damage in COVID Patients

White lung syndrome (a hallmark symptom of acute respiratory distress syndrome) now occurring in severe COVID infections in China, is a sign that the virus has deeply infected the lungs and may have caused cytokine storms (a severe immune reaction in the body) in patients.
Other complications that arise from COVID-19 involving the lungs are pulmonary fibrosis and hypoxia.

Ivermectin Can Reduce Bacterial Co-Infections for COVID Patients

Bacterial coinfections are common in respiratory viral infections, and patients with COVID-19 are no exception. Patients with co-infections were more likely to die in intensive care than those without.
Repurposing drugs is the best accelerator for prophylactic development because it can save developers anywhere from three to 12 years as experts can reuse the data from previous clinical trials and other experiments.

https://www.theepochtimes.com/health/ivermectin-could-population-wide-distribution-have-prevented-chinas-recent-mass-covid-outbreak_5007189.html?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge

No comments:

Subscribe to: Post Comments (Atom)